This month, Quantify Research’s Emilie Toresson Grip, Helena Skröder Löveborn and Oskar Ström published a study in Diabetes Care, using a uniquely collected NAFLD dataset (“HERALD”).
Using HERALD, the study showed that having or acquiring additional traits of metabolic syndromes increased the rate of progression to major adverse liver outcomes (MALO) in patients with T2D.
This information may be used to inform screening programs for MALO.
Read the full article here: https://diabetesjournals.org/care/article/doi/10.2337/dc23-1937/154337/Metabolic-Syndrome-Traits-Increase-the-Risk-of
